Health & Environmental Research Online (HERO)


Print Feedback Export to File
6951222 
Journal Article 
Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension 
Scoper, SV; Kabat, AG; Owen, GR; Stroman, DW; Kabra, BP; Faulkner, R; Kulshreshtha, AK; Rusk, C; Bell, B; Jamison, T; Bernal-Perez, LF; Brooks, AC; Nguyen, VA; , 
2008 
Yes 
Advances in Therapy
ISSN: 0741-238X
EISSN: 1865-8652 
English 
18309465 
TobraDex ophthalmic suspension (tobramycin 0.3%, dexamethasone 0.1%; Alcon Laboratories Inc, Fort Worth, Tex) is frequently used for inflammatory ocular conditions where a risk of bacterial ocular infection exists. A new formulation, TobraDex ST ophthalmic suspension (tobramycin 0.3%, dexamethasone 0.05%, Alcon), utilises a novel suspension technology to reduce viscosity and help prevent settling in the container.